Experts update timetable of COVID-19 vaccine trials for children under 12; vaccine mandates happen nationwide in wake of the Pfizer/BioNTech approval; sedentary behavior is associated with 7-fold increased risk of stroke.
With the Pfizer/BioNTech COVID-19 vaccine receiving full approval yesterday from the FDA for persons aged 16 and older, an article by NBC News notes what steps remain in vaccine clinical trials for children younger than 12 years who can't yet get vaccinated. Notably, vaccinating younger children may require extra scrutiny and study, with the FDA asking for 4 to 6 months of follow-up safety data from the children’s clinical trials vs 2 months in adult trials. Ongoing studies by Pfizer on children aged 5 to 11 years are expected to be completed in September, with data on toddlers up to age 4 available soon after.
A flurry of vaccine mandates by entities ranging from the Pentagon to Disney were reported yesterday after the full approval of the Pfizer vaccine, with President Joe Biden encouraging private employers to similarly issue mandates at their companies. New York City also will require all Department of Education employees to be at least partially vaccinated by September 27, whereas a lawsuit challenging Florida Governor Ron DeSantis’ mask mandate ban will be heard this week.
As reported by CNN, a study published in Stroke found that adults under 60 years who spend 8 hours or more sitting each day and are not physically active have a 7-fold higher risk of stroke than people who report sedentary behavior for less than 4 hours and exercise at least 10 minutes each day. To curb the risk of stroke, the American Heart Association recommends that adults get at least 150 minutes of moderate-intensity exercise per week. Alcohol consumption, which has been associated with stroke risk in prior research, was also noted as a modifiable risk factor.
Study Shows Higher Infection Risk in Patients With T1D in Primary, Secondary Care
November 22nd 2023Researchers concluded there is a clinically important increase in infection risk among patients with T1D in both primary care and hospital settings, and that guidelines must be developed to reflect this risk and encourage earlier treatment.
Read More
Navigating Medicare's Part D Subsidy Program to Achieve Value-Based Care
May 26th 2023On this episode of Managed Care Cast, we speak with the lead researcher from a study published in the May 2023 issue of The American Journal of Managed Care® about the impact of low-income subsidies on the uptake and equitable use of expensive orally administered antimyeloma therapy.
Listen
AHN’s Center for Inclusion Health Personalizing Equitable Care Delivery for Marginalized Communities
February 28th 2023On this episode of Managed Care Cast, we speak with Elizabeth Cuevas, MD, division chief of Allegheny Health Network’s (AHN) Center for Inclusion Health, on prevalent health inequities facing marginalized communities and strategies to identify and address these issues.
Listen
Study Reveals Racial Disparities in Immune Tolerance Induction Treatment for Hemophilia
November 14th 2023New research highlights racial disparities in hemophilia care, revealing that Black and Hispanic patients are significantly less likely to receive immune tolerance induction treatment compared with White patients, even after considering clinical factors.
Read More
Study Shows Higher Infection Risk in Patients With T1D in Primary, Secondary Care
November 22nd 2023Researchers concluded there is a clinically important increase in infection risk among patients with T1D in both primary care and hospital settings, and that guidelines must be developed to reflect this risk and encourage earlier treatment.
Read More
Navigating Medicare's Part D Subsidy Program to Achieve Value-Based Care
May 26th 2023On this episode of Managed Care Cast, we speak with the lead researcher from a study published in the May 2023 issue of The American Journal of Managed Care® about the impact of low-income subsidies on the uptake and equitable use of expensive orally administered antimyeloma therapy.
Listen
AHN’s Center for Inclusion Health Personalizing Equitable Care Delivery for Marginalized Communities
February 28th 2023On this episode of Managed Care Cast, we speak with Elizabeth Cuevas, MD, division chief of Allegheny Health Network’s (AHN) Center for Inclusion Health, on prevalent health inequities facing marginalized communities and strategies to identify and address these issues.
Listen
Study Reveals Racial Disparities in Immune Tolerance Induction Treatment for Hemophilia
November 14th 2023New research highlights racial disparities in hemophilia care, revealing that Black and Hispanic patients are significantly less likely to receive immune tolerance induction treatment compared with White patients, even after considering clinical factors.
Read More
2 Clarke Drive
Cranbury, NJ 08512